Supported by Liver Center of Excellence Research Fund, Virginia Mason Medical Center to K.V.K.
Steatohepatitis/Metabolic Liver Disease
Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis
Version of Record online: 27 MAY 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 60, Issue 1, pages 133–145, July 2014
How to Cite
Handa, P., Maliken, B. D., Nelson, J. E., Morgan-Stevenson, V., Messner, D. J., Dhillon, B. K., Klintworth, H. M., Beauchamp, M., Yeh, M. M., Elfers, C. T., Roth, C. L. and Kowdley, K. V. (2014), Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis. Hepatology, 60: 133–145. doi: 10.1002/hep.26946
Potential conflict of interest: Nothing to report.
See Editorial on Page 22
- Issue online: 26 JUN 2014
- Version of Record online: 27 MAY 2014
- Accepted manuscript online: 21 NOV 2013 01:57AM EST
- Manuscript Accepted: 18 NOV 2013
- Manuscript Revised: 15 NOV 2013
- Manuscript Received: 11 JUL 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.